Timo Otonkoski was trained as a Pediatric Endocrinologist at the Children’s Hospital in Helsinki. In 2007-24 he acted as the Professor of Medical Stem Cell Research at the University of Helsinki where he now continues research as an emeritus. His group has developed novel approaches for the pancreatic differentiation of human pluripotent stem cells into functional stem-cell derived islets. The Otonkoski group belongs to the Centre of Excellence in Stem Cell Metabolism of the Research Council of Finland. Dr. Otonkoski received the Finnish physician/scientist Äyräpää Price in 2018, and the Albert Renold Prize of the European Association for the Study of Diabetes in 2019.
